Reduction of the incidence and severity of collagen-induced arthritis by constitutive Nur77 expression in the T cell lineage.

OBJECTIVE To test the hypothesis that constitutive expression of Nur77 in the T cell lineage will suppress the development and pathogenesis of collagen-induced arthritis (CIA) and to understand the mechanisms by which Nur77 overexpression influences the arthritogenic response to type II collagen (CII). METHODS Nur77-transgenic and wild-type C57BL/6 mice were immunized with CII and were monitored for the development and severity of arthritis. Pathologic changes were examined by histology and radiography. The effects of Nur77 overexpression on immune responses were evaluated by cytokine production in vitro and serum levels of CII-specific antibodies. Sensitivity of T cells to apoptosis induction was analyzed in vitro following stimulation with anti-CD3 monoclonal antibody or glucocorticoid. RESULTS The incidence and severity of CIA was significantly decreased in Nur77-transgenic mice compared with wild-type controls. Attenuation of the disease was associated with increased apoptosis induction in transgenic T cells and decreased production of CII-specific IgG2a antibodies in transgenic mice. Overexpression of Nur77 in the T cell compartment did not affect Th1/Th2 cytokine production or balance. CONCLUSION Nur77 overexpression in the T cell lineage attenuates the development and progression of CIA, probably by promoting activation-induced T cell apoptosis and by inhibiting CII-specific antibody production.

[1]  D. Littman,et al.  Nuclear Hormone Receptors in T Lymphocytes , 2002, Cell.

[2]  I. Wicks,et al.  Collagen‐induced arthritis in C57BL/6 (H‐2b) mice: new insights into an important disease model of rheumatoid arthritis , 2000, European journal of immunology.

[3]  A. Vallejo,et al.  Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients. , 1998, Journal of immunology.

[4]  T. Kipps,et al.  Deficient Fas ligand expression by synovial lymphocytes from patients with rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[5]  P. Emery,et al.  Inhibition of T cell apoptosis in the rheumatoid synovium. , 1997, The Journal of clinical investigation.

[6]  F. Weih,et al.  Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Maini,et al.  Anti-cytokine therapy in rheumatoid arthritis. , 1995, Bailliere's clinical rheumatology.

[8]  F. Chan,et al.  A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. , 1995, Immunity.

[9]  G. Firestein,et al.  Apoptosis in rheumatoid arthritis synovium. , 1995, The Journal of clinical investigation.

[10]  B. Calnan,et al.  Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas , 1994, Nature.

[11]  G. Mayrhofer,et al.  Treatment of collagen‐induced arthritis in rats with a monoclonal antibody against the α/β T cell antigen receptor , 1991 .

[12]  R. Holmdahl,et al.  Anti‐T cell receptor antibody treatment of rats with established autologous collagen‐induced arthritis: suppression of arthritis without reduction of anti‐type II collagen autoantibody levels , 1991, European journal of immunology.

[13]  R. Holmdahl,et al.  Type II Collagen Autoimmunity in Animals and Provocations Leading to Arthritis , 1990, Immunological reviews.

[14]  R. Jonsson,et al.  Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. , 1988, Arthritis and rheumatism.

[15]  R. Jonsson,et al.  A demineralization procedure for immunohistopathological use. EDTA treatment preserves lymphoid cell surface antigens. , 1986, Journal of immunological methods.